137 related articles for article (PubMed ID: 9626118)
1. Beneficial effect of diazoxide in obese hyperinsulinemic adults.
Alemzadeh R; Langley G; Upchurch L; Smith P; Slonim AE
J Clin Endocrinol Metab; 1998 Jun; 83(6):1911-5. PubMed ID: 9626118
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of metformin in normoglycemic morbidly obese adolescents.
Kay JP; Alemzadeh R; Langley G; D'Angelo L; Smith P; Holshouser S
Metabolism; 2001 Dec; 50(12):1457-61. PubMed ID: 11735093
[TBL] [Abstract][Full Text] [Related]
3. No effect of inhibition of insulin secretion by diazoxide on weight loss in hyperinsulinaemic obese subjects during an 8-week weight-loss diet.
Due A; Flint A; Eriksen G; Møller B; Raben A; Hansen JB; Astrup A
Diabetes Obes Metab; 2007 Jul; 9(4):566-74. PubMed ID: 17587399
[TBL] [Abstract][Full Text] [Related]
4. Chronic suppression of insulin by diazoxide alters the activities of key enzymes regulating hepatic gluconeogenesis in Zucker rats.
Alemzadeh R; Holshouser S; Massey P; Koontz J
Eur J Endocrinol; 2002 Jun; 146(6):871-9. PubMed ID: 12039709
[TBL] [Abstract][Full Text] [Related]
5. Modification of insulin resistance by diazoxide in obese Zucker rats.
Alemzadeh R; Slonim AE; Zdanowicz MM; Maturo J
Endocrinology; 1993 Aug; 133(2):705-12. PubMed ID: 8344209
[TBL] [Abstract][Full Text] [Related]
6. Antiobesity effect of diazoxide in obese Zucker rats.
Alemzadeh R; Jacobs W; Pitukcheewanont P
Metabolism; 1996 Mar; 45(3):334-41. PubMed ID: 8606640
[TBL] [Abstract][Full Text] [Related]
7. Effect of diazoxide on brain capillary insulin receptor binding and food intake in hyperphagic obese Zucker rats.
Alemzadeh R; Holshouser S
Endocrinology; 1999 Jul; 140(7):3197-202. PubMed ID: 10385415
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of a high-protein, low-carbohydrate diet on weight control and cardiovascular risk markers in obese hyperinsulinemic subjects.
Brinkworth GD; Noakes M; Keogh JB; Luscombe ND; Wittert GA; Clifton PM
Int J Obes Relat Metab Disord; 2004 May; 28(5):661-70. PubMed ID: 15007396
[TBL] [Abstract][Full Text] [Related]
9. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of hyperinsulinemia by NN414, a SUR1/Kir6.2 selective K-adenosine triphosphate channel opener, improves glucose tolerance and lipid profile in obese Zucker rats.
Alemzadeh R; Fledelius C; Bodvarsdottir T; Sturis J
Metabolism; 2004 Apr; 53(4):441-7. PubMed ID: 15045689
[TBL] [Abstract][Full Text] [Related]
11. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
[TBL] [Abstract][Full Text] [Related]
12. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.
Svensson J; Lönn L; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Boseaus I; Sjöström L; Bengtsson BA
J Clin Endocrinol Metab; 1998 Feb; 83(2):362-9. PubMed ID: 9467542
[TBL] [Abstract][Full Text] [Related]
13. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?
Brochu M; Tchernof A; Dionne IJ; Sites CK; Eltabbakh GH; Sims EA; Poehlman ET
J Clin Endocrinol Metab; 2001 Mar; 86(3):1020-5. PubMed ID: 11238480
[TBL] [Abstract][Full Text] [Related]
14. Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial.
Eliasson B; Gudbjörnsdottir S; Cederholm J; Liang Y; Vercruysse F; Smith U
Int J Obes (Lond); 2007 Jul; 31(7):1140-7. PubMed ID: 17264849
[TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
[TBL] [Abstract][Full Text] [Related]
16. Use of quality control indices in moderately hypocaloric Mediterranean diet for treatment of obesity.
De Lorenzo A; Petroni ML; De Luca PP; Andreoli A; Morini P; Iacopino L; Innocente I; Perriello G
Diabetes Nutr Metab; 2001 Aug; 14(4):181-8. PubMed ID: 11716286
[TBL] [Abstract][Full Text] [Related]
17. Weight loss in obese men by caloric restriction and high-dose diazoxide-mediated insulin suppression.
van Boekel G; Loves S; van Sorge A; Ruinemans-Koerts J; Rijnders T; de Boer H
Diabetes Obes Metab; 2008 Dec; 10(12):1195-203. PubMed ID: 18476985
[TBL] [Abstract][Full Text] [Related]
18. Diazoxide down-regulates leptin and lipid metabolizing enzymes in adipose tissue of Zucker rats.
Standridge M; Alemzadeh R; Zemel M; Koontz J; Moustaid-Moussa N
FASEB J; 2000 Mar; 14(3):455-60. PubMed ID: 10698960
[TBL] [Abstract][Full Text] [Related]
19. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
Hadigan C; Corcoran C; Stanley T; Piecuch S; Klibanski A; Grinspoon S
J Clin Endocrinol Metab; 2000 Jan; 85(1):35-41. PubMed ID: 10634360
[TBL] [Abstract][Full Text] [Related]
20. Diazoxide enhances adipose tissue protein kinase B activation and glucose transporter-4 expression in obese Zucker rats.
Alemzadeh R; Zhang J; Tushaus K; Koontz J
Med Sci Monit; 2004 Mar; 10(3):BR53-60. PubMed ID: 14976464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
